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Stimulation of locomotor activity following injection of 
dopamine into the nucleus accumbens
Recently we have observed that bilateral injection of ergometrine into the nucleus 
accumbens of rats results in a strong and long-lasting enhancement of locomotor 
activity (Pijnenburg, Woodruff & van Rossum, 1973). This effect was antagonized 
by low doses of haloperidol and pimozide. The hypothesis was proposed that this 
enhanced locomotor activity was elicited by a stimulation of dopamine receptors in 
the nucleus accumbens.
We now report that administration of dopamine directly into the nucleus accumbens 
of nialamide-pretreated rats produces a pattem of enhanced locomotor activity 
similar to that seen after ergometrine.
Seven male Wistar rats (200-220 g) were implanted with double barrelled cannulas 
in each side of the nucleus accumbens (coordinates A 9-4, L 1-2 and H —0-6 accord- 
ing to the atlas of König & Klippel, 1963). These animals were used for all experi- 
ments with 5-8 days between experiments. The animals were subsequently killed 
and brains were sectioned to determine the position of the cannulas. For details of 
the experimental procedure see Pijnenburg & others (1973). Injections were made by 
means of a 5 fA Hamilton syringe with a 31 gauge needle. The injection volume was 
0-5 /Lil. Dopamine HC1 and (—)-noradrenaline (—)-hydrogen tartrate were dissolved 
in saline.
Locomotor activity was measured in activity cages, equipped with photoelectric 
cells and recorded on a cumulative recorder.
The rats were always pretreated with the monoamine oxidase inhibitor nialamide 
(100 mg kg-1 i.p.) 18 h before administration of saline, dopamine or noradrenaline. 
Injection of dopamine (5 /x.g) to each side of the nucleus produced a strong enhance­
ment of locomotor activity, which started in 5 animals within 10 min of injection and 
lasted for up to 4 h, reaching a peak at about 1 h retuming to 0 over the next 3 h with 
the most rapid decline over the last 30 min. In two rats, in which the injection site 
was found to be at the border of the nucleus accumbens, stimulation of locomotor 
activity started after 20 and 30 min respectively and failed to reach the level seen in 
the other rats. This is probably the reason for the large variability in the results 
(see Table 1).
Injection of noradrenaline (5-0 (ig) into each side of the nucleus accumbens of the 
same rats produced enhanced locomotor activity in 5 of the 7 animals but this was
Table 1. The effect on locomotor activity o f injections of dopamine and noradrenaline 
into each side o f the nucleus accumbens of the rat. Nialamide 100 mg kg-1 
was given 18 h before the injection of dopamine or noradrenaline (n =  
number of experiments).
Mean locomotor activity ±  s.e. during
Dose n 1 h 2 h 3 h 4 h
Saline 7 138 ± 2 8 43 ± 6 35 ±  10 13 ±  5
Dopamine !! 5-o 7 3652 ±  1010a 4672 ±  8926 3884 ±  889» 2012 ±  627°
10 7 1344 ± 4 6 3 4 784 ±  261d 185 ±  58d 67 ± 2 5
Noradrenaline . 5-0 7 580 ±  232d 1012 ±  413d 689 ±  30d 408 ±  18d
a P  <0-02 both with respect to saline and noradrenaline 5-0 /xg.
6 P  <0-01 both with respect to saline and noradrenaline 5-0 /xg. 
c P  <0-02 with respect to saline, P  <0-05 with respect to noradrenaline 5-0 jug. 
d P  <0-05 with respect to saline.
Statistical significance calculated according to Student’s /-test for paired comparison.
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significantly less than after the dopamine (5-0 fig) and started after 30-40 min and 
lasted about 4 h. The 2 rats with offset injection sites showed no stimulation of 
locomotor activity after noradrenaline.
Even a dose of 1-0 fig of dopamine was effective in 5 of the 7 rats who responded 
with enhanced locomotor activity within 10 min. The degree of motor activity, 
which was highest during the first hour, was less than after the 5-0 /x.g dose and lasted 
for about 2-3 h (see Table 1). The 2 animals with offset injection sites did not 
respond. Injections of saline were ineffective.
Thus, stimulation of dopamine receptors in the nucleus accumbens results in en­
hanced locomotor activity. The behavioural pattern showed the same characteristics 
as seen after injection of ergometrine, i.e. continuous exploring activity, except that 
the time for the appearance of locomotor stimulation was shorter.
This finding favours the assumption that ergometrine has dopamine-stimulating 
properties in the rat brain. This is in agreement with observations on some other 
ergot-derivatives. For instance, it was found by Stone (1973) that agroclavine 
produced “stereotyped” sniffing and gnawing behaviour. Corrodi, Fuxe & others 
(1973) found that ergocornine and 2-Br-a-cryptine (CB154) mimicked the action of 
apomorphine in rats with a unilateral 6-hydroxydopamine-induced degeneration 
of the nigro-neostriatal dopamine pathway and produced a decrease in the dopamine 
tumover in the neostriatum and the limbic system; they concluded that the main 
action of these drugs was a direct dopamine receptor stimulation of long duration.
Several studies have indicated that dopamine might play an important role in the 
motor stimulation seen after injection of psychomotor stimulant drugs (van Rossum & 
Hurkmans, 1964; Maj, & Grabowska & Gajda, 1972; Andén, Strömbom & Svensson, 
1973). Although we would not exclude the role of noradrenaline, it is possible that 
these drugs exert their effect in part via the dopamine system in the nucleus accumbens.
Bilateral injection of dopamine into the caudate nucleus of nialamide-pretreated 
rats did not result in such a strong locomotor activity. Although with doses of 10 and 
50 /j,g dopamine there was a slight to moderate increase of motor activity, the pre- 
dominant feature was stereotyped sniffing behaviour, which appeared 30-40 min 
after the injection (D. Malec, unpublished). This was not seen in the present experi- 
ments which provide evidence that the mesolimbic dopamine system with cell bodies 
in the A 10 group (classification according to Dahlström & Fuxe, 1965) and nerve 
terminals in the nucleus accumbens and tuberculum olfactorium (Andén, Dahlström 
& others, 1966; Arbuthnott, Crow & others, 1970; Ungerstedt, 1971) is functionally 
different from the nigrostriatal dopamine system.
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